Sarepta Therapeutics, Inc. (SRPT): A Bull Case Theory

Yahoo FinanceDec 15 10:16

Solid Biosciences Positioned For Next-Gen Duchenne Muscular Dystrophy Treatment Success: Analyst

BenzingaDec 14 02:52

FDA's New Accelerated Approval Guidance to Benefit Rare Disease Drug Development, Analysts Believe | NASDAQ:SRPT

Proactive InvestorsDec 14 00:17

Wall Street Analysts See a 47.95% Upside in Sarepta Therapeutics (SRPT): Can the Stock Really Move This High?

Yahoo FinanceDec 13 22:55

Antisense & RNAi Therapeutics Market Report 2024, Featuring Profiles of Alnylam Pharmaceuticals, Arbutus Biopharma, Benitec Biopharma, GSK, Ionis Pharmaceuticals, Sanofi, Sarepta Therapeutics & More - ResearchAndMarkets.com

BusinesswireDec 12 01:41

Based On Its ROE, Is Sarepta Therapeutics, Inc. (NASDAQ:SRPT) A High Quality Stock?

Simply Wall StDec 10 18:05